Farmajes
ActiveFarmajes has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €86k and a net result of €30k. Equity is growing by ~7.2% per year across the filed fiscal years. Its solvency ranks better than 14% of 9622 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.9% (low).
Checked score
Score 2024
54
/ 100
Fair
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability71▼-10
Solvency31=
Growth78=
Track record100
Bankruptcy probability, 12 months
0.9%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €4.5k at 30 days acceptable
Liquidity short (current ratio 0.58 against 0.58 in 2023; short-term debt: 45.5% and cash: 3.7% of total assets), and 93.8% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 14% of 9622 sector peers (2024).
NBB · sector comparisonPosition among 9622 sector peers
Solvency
better than 14%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 23-06-2025, 38 days ahead of the deadline.
NBB · 7 filingsDeviation from the deadline
2025
not confirmed
2024
38 d early
2023
30 d early
2022
26 d early
2021
17 d early
2020
43 d early
2019
23 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, abbreviated schema
Equity
€86k=
2023 · €86k
2018: €-33k
2019: €75k
2020: €75k
2021: €50k
2022: €75k
2023: €86k
2018 → 2024
Total assets
€1.39M▲ 0.3%
2023 · €1.38M
2018: €190k
2019: €638k
2020: €563k
2021: €1.23M
2022: €1.36M
2023: €1.38M
2018 → 2024
Net result
€30k▼ 78.3%
2023 · €140k
2018: €-52k
2019: €108k
2020: €128k
2021: €-25k
2022: €68k
2023: €140k
2018 → 2024
Working capital
€-264k▼ 10.3%
2023 · €-240k
2018: €-48k
2019: €82k
2020: €33k
2021: €-234k
2022: €-241k
2023: €-240k
2018 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20202021202220232024Trend
Equity€75k-€50k▼ 33.1%€75k▲ 50.1%€86k▲ 14.3%€86k=
Operating result€124k-€-18k€83k€158k▲ 90.1%€49k▼ 69.2%
Net result€128k-€-25k€68k€140k▲ 107%€30k▼ 78.3%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 69% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €1.39M
Fixed assets
€1.02M▼ 3.3%
Current assets
€369k▲ 12.2%
Equity and liabilities €1.39M
Equity
€86k=
Debt
€1.30M▲ 0.4%
The debt ratio stays at 93.8%.
Key figures and ratios
EBITDA
€101k▼
2023 · €208k
Cash flow
€83k▼
2023 · €190k
Solvency
6.2%▼
2023 · 6.2%
Current ratio
0.58▲
2023 · 0.58
Quick ratio
0.41▲
2023 · 0.38
Debt / equity
15.17▲
2023 · 15.11
ROE
35.2%▼
2023 · 162.6%
ROA
2.2%▼
2023 · 10.1%
Interest coverage
6.85▼
2023 · 14.49
Debt
€1.30M▲
2023 · €1.30M
Debt ≤ 1 year
€633k▲
2023 · €568k
Debt > 1 year
€670k▼
2023 · €730k
Income taxes
€4k▼
2023 · €4k
Staff costs
€139k▲
2023 · €80k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€1.38M€1.39M▲
Fixed assets21/28€1.06M€1.02M▼
Intangible fixed assets21€46k€36k▼
Tangible fixed assets22/27€1.01M€985k▼
Land and buildings22€970k€941k▼
Plant, machinery and equipment23€1k€11k▲
Furniture and vehicles24€38k€33k▼
Current assets29/58€329k€369k▲
Stocks and contracts in progress3€115k€112k▼
Stocks30/36€115k€112k▼
Amounts receivable within one year40/41€149k€195k▲
Trade receivables40€146k€190k▲
Other amounts receivable41€3k€5k▲
Cash at bank and in hand54/58€53k€51k▼
Deferred charges and accrued income490/1€11k€10k▼
Equity and liabilities
Total equity and liabilities10/49€1.38M€1.39M▲
Equity10/15€86k€86k=
Contributions10/11€19k€19k=
Reserves13€67k€67k=
Distributable reserves133€67k€67k=
Profit (loss) carried forward14€0€0=
Amounts payable17/49€1.30M€1.30M▲
Amounts payable after more than one year17€730k€670k▼
Financial debts170/4€730k€670k▼
Amounts payable within one year42/48€568k€633k▲
Current portion of amounts payable after more than one year42€55k€60k▲
Trade debts44€316k€308k▼
Suppliers440/4€316k€308k▼
Taxes, remuneration and social security45€7k€17k▲
Taxes450/3€881€26▼
Remuneration and social security454/9€6k€17k▲
Other amounts payable47/48€191k€248k▲
Accrued charges and deferred income492/3€640€788▲
Income statement
Code20232024
Remuneration, social security and pensions62€80k€139k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€50k€52k▲
Other operating charges640/8€7k€3k▼
Gross operating margin9900€295k€243k▼
Operating profit (loss)9901€158k€49k▼
Financial income75/76B€294€367▲
Recurring financial income75€294€367▲
Financial charges65/66B€14k€15k▲
Recurring financial charges65€14k€15k▲
Profit (loss) for the period before taxes9903€144k€34k▼
Income taxes67/77€4k€4k▼
Profit (loss) for the period9904€140k€30k▼
Profit (loss) for the period to be appropriated9905€140k€30k▼
Appropriation of the result
Profit (loss) to be appropriated9906€140k€30k▼
Profit (loss) brought forward from the previous period14P€0-
Transfer to equity691/2€11k€0▼
To other reserves6921€11k€0▼
Profit to be distributed694/7€129k€30k▼
Return on contributions (dividend)694-€10k
Directors or managers695€129k€20k▼
Social balance
Average headcount (FTE)90871.52.1▲
The notes to these accounts (14 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
23-06
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
01-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Highest result since 2018net €140k ▲107%
Operating result €158k, net result €140k, both a record.
05-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
31-12
Financial
Back to profitnet €68k
Net result €68k after one loss-making year.
14-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
18-06
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
08-07
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
2019
31-12
Financial
Back to profitnet €108k
Net result €108k after one loss-making year.
25-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
6 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Antwerpen · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Lange Koepoortstraat 12000 AntwerpenGround area
58 m²
Building footprint
58 m²
Volume, LiDAR
944 m³
Parcel 11002A0787/00B000, Flanders · tallest building 17.9 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
Farmajes
since 20172.268.590.864
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11002A0787/00B000 | Flanders | 58 m² | 1 · 58 m² | 17.9 m · 6 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
VANCOPHAR
BE 0540.905.553
Bierbeek · Eq €86k
ANTOINE DERBAUD
BE 0786.472.040
Ham-sur-Heure-Nalinnes · Eq €86k
APOTHEEK DE MAN
BE 0442.732.447
Sint-Truiden · Eq €86k
apotheek Maes
BE 0874.956.826
Hoegaarden · Eq €86k
APOTHEEK VAN OVERBERGE - VAN DEN STEEN
BE 0457.932.941
Gent · Eq €86k
Of 5,223 companies in sector 47730 we hold annual accounts for 3,862. 3,313 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-09-2017
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 17-09-2026. Scores and ratios are computed by Checked and are not a credit decision.